Search

Robert W. Downs

Examiner (ID: 17152)

Most Active Art Unit
2308
Art Unit(s)
2762, 4762, 2309, 2308, 2165
Total Applications
581
Issued Applications
448
Pending Applications
24
Abandoned Applications
109

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16969404 [patent_doc_number] => 11065351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-20 [patent_title] => Methods for diagnosing and monitoring eosinophilic esophagitis [patent_app_type] => utility [patent_app_number] => 16/502328 [patent_app_country] => US [patent_app_date] => 2019-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10971 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502328 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/502328
Methods for diagnosing and monitoring eosinophilic esophagitis Jul 2, 2019 Issued
Array ( [id] => 17406079 [patent_doc_number] => 11246940 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-15 [patent_title] => Peptides whose uptake in cells is controllable [patent_app_type] => utility [patent_app_number] => 16/457763 [patent_app_country] => US [patent_app_date] => 2019-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 39792 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457763 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/457763
Peptides whose uptake in cells is controllable Jun 27, 2019 Issued
Array ( [id] => 14991141 [patent_doc_number] => 20190314528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => TARGETED THERAPEUTICS [patent_app_type] => utility [patent_app_number] => 16/454586 [patent_app_country] => US [patent_app_date] => 2019-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34014 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454586 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/454586
TARGETED THERAPEUTICS Jun 26, 2019 Abandoned
Array ( [id] => 14990653 [patent_doc_number] => 20190314284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => Cleavable Lipids [patent_app_type] => utility [patent_app_number] => 16/452353 [patent_app_country] => US [patent_app_date] => 2019-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16452353 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/452353
Cleavable lipids Jun 24, 2019 Issued
Array ( [id] => 17306350 [patent_doc_number] => 11207433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-28 [patent_title] => Imaging agents and uses thereof [patent_app_type] => utility [patent_app_number] => 16/449147 [patent_app_country] => US [patent_app_date] => 2019-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 8323 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449147 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/449147
Imaging agents and uses thereof Jun 20, 2019 Issued
Array ( [id] => 19134575 [patent_doc_number] => 11969484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Composition containing a somatostatin analogue for radiopharmaceutical use [patent_app_type] => utility [patent_app_number] => 17/251426 [patent_app_country] => US [patent_app_date] => 2019-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7619 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251426 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/251426
Composition containing a somatostatin analogue for radiopharmaceutical use Jun 19, 2019 Issued
Array ( [id] => 19273280 [patent_doc_number] => 12023387 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => NIR-II emissive luminogens [patent_app_type] => utility [patent_app_number] => 17/251961 [patent_app_country] => US [patent_app_date] => 2019-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 21 [patent_no_of_words] => 5014 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251961 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/251961
NIR-II emissive luminogens Jun 13, 2019 Issued
Array ( [id] => 16941001 [patent_doc_number] => 11053222 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-06 [patent_title] => Fluorescent compounds [patent_app_type] => utility [patent_app_number] => 16/436512 [patent_app_country] => US [patent_app_date] => 2019-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 81 [patent_no_of_words] => 25909 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16436512 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/436512
Fluorescent compounds Jun 9, 2019 Issued
Array ( [id] => 18664915 [patent_doc_number] => 11771780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-03 [patent_title] => Method for preparing an Fe-tCDTA contrast agent and product obtainable by the method [patent_app_type] => utility [patent_app_number] => 17/252261 [patent_app_country] => US [patent_app_date] => 2019-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2376 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252261 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/252261
Method for preparing an Fe-tCDTA contrast agent and product obtainable by the method Jun 5, 2019 Issued
Array ( [id] => 15264933 [patent_doc_number] => 20190381200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => FREE PSA ANTIBODIES AS DIAGNOSTICS, PROGNOSTICS AND THERAPEUTICS FOR PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 16/430041 [patent_app_country] => US [patent_app_date] => 2019-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430041 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/430041
Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer Jun 2, 2019 Issued
Array ( [id] => 16946793 [patent_doc_number] => 20210205484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => SPATIAL MAPPING OF KIDNEY FUNCTIONS [patent_app_type] => utility [patent_app_number] => 17/059606 [patent_app_country] => US [patent_app_date] => 2019-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059606 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/059606
Spatial mapping of kidney functions May 30, 2019 Issued
Array ( [id] => 17748131 [patent_doc_number] => 20220226334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => ANTIBODY CONJUGATE AND APPLICATION OF PHARMACEUTICAL COMPOSITION THEREOF [patent_app_type] => utility [patent_app_number] => 17/612849 [patent_app_country] => US [patent_app_date] => 2019-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13485 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612849 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/612849
ANTIBODY CONJUGATE AND APPLICATION OF PHARMACEUTICAL COMPOSITION THEREOF May 20, 2019 Abandoned
Array ( [id] => 16175596 [patent_doc_number] => 20200222564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof [patent_app_type] => utility [patent_app_number] => 16/393784 [patent_app_country] => US [patent_app_date] => 2019-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4109 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393784 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/393784
Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof Apr 23, 2019 Abandoned
Array ( [id] => 15206455 [patent_doc_number] => 20190365914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => NOVEL ANTIBODY-DRUG CONJUGATES AND THE USE OF SAME IN THERAPY [patent_app_type] => utility [patent_app_number] => 16/381803 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15032 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 520 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381803 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/381803
Antibody-drug conjugates and the use of same in therapy Apr 10, 2019 Issued
Array ( [id] => 14833563 [patent_doc_number] => 20190275182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => RADIOTRACER COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 16/375223 [patent_app_country] => US [patent_app_date] => 2019-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8054 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16375223 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/375223
Radiotracer compositions and methods Apr 3, 2019 Issued
Array ( [id] => 14833549 [patent_doc_number] => 20190275175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => Carbon Nanotubes for Imaging and Drug Delivery [patent_app_type] => utility [patent_app_number] => 16/353743 [patent_app_country] => US [patent_app_date] => 2019-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9591 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353743 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/353743
Carbon Nanotubes for Imaging and Drug Delivery Mar 13, 2019 Abandoned
Array ( [id] => 19135623 [patent_doc_number] => 11970554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Labeled oxytocin and method of manufacture and use [patent_app_type] => utility [patent_app_number] => 16/976912 [patent_app_country] => US [patent_app_date] => 2019-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20532 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976912 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/976912
Labeled oxytocin and method of manufacture and use Feb 28, 2019 Issued
Array ( [id] => 16955962 [patent_doc_number] => 11059802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-13 [patent_title] => Carbonic anhydrase targeting agents and methods of using same [patent_app_type] => utility [patent_app_number] => 16/286901 [patent_app_country] => US [patent_app_date] => 2019-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 21324 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16286901 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/286901
Carbonic anhydrase targeting agents and methods of using same Feb 26, 2019 Issued
Array ( [id] => 14435793 [patent_doc_number] => 20190175768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => POLYMER BASED RADIONUCLIDE CONTAINING PARTICULATE MATERIAL [patent_app_type] => utility [patent_app_number] => 16/280171 [patent_app_country] => US [patent_app_date] => 2019-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3492 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16280171 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/280171
Polymer based radionuclide containing particulate material Feb 19, 2019 Issued
Array ( [id] => 16582730 [patent_doc_number] => 20210017132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => NON-AGGREGATING HEPTAMETHINE CYANINE FLUOROPHORES FOR IN VIVO IMAGING [patent_app_type] => utility [patent_app_number] => 16/969902 [patent_app_country] => US [patent_app_date] => 2019-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15701 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969902 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/969902
Non-aggregating heptamethine cyanine fluorophores for in vivo imaging Feb 14, 2019 Issued
Menu